Cite

HARVARD Citation

    Stradner, M. et al. (2014). AB0266 Baseline CD4+ T Lymphocyte Count Predicts Clinical Response to Rituximab in Rheumatoid Arthritis. Annals of the rheumatic diseases. p. 892. [Online]. 
  
Back to record